On April 25, 2018, Lifetech was included in the ranking of the "the Most Attentive List Company by Institution Investors of Shenzhen-Hongkong Stock Connect "
On April 19, 2018, Lifetech (1302.HK) was awarded as "listed company with the Best Medical Devies and Diagnosis " at the 2018 CHC ·7th China Healthcare Investment CEO Conference.
From April 20 to 21, the 2018 Vascular Innovation Symposium was held in Beijing, with a view to promoting innovations in the field of vascular surgery and providing a platform for the exchange of and cooperation on innovative ideas.
From April 24 to 27, 2018, the Charing Cross Symposium was held in London. Lifetech attended the academic event for the first time
From April 13 to 15, 2018, the Eighth China Vascular Surgical Complications Forum & the Fourteenth Annual Zhejiang Vascular Surgery Congress was held in Hangzhou.
From April 13 to 15, the XiaoXiang-International Cardiology Conference 2018 was successfully held in Changsha. Lifetech attended the academic event and held a satellite meeting.
At 19:30 on April 10, 2018, doctors from the Guangdong-Hong Kong-Macao Greater Bay Area completed the first minimalist LAA closure procedure by using LAmbre™.
The SCC 2018 was held in Guangzhou from April 5 to 8, 2018. Lifetech attended the academic event and held a satellite meeting.
On March 28, 2018 in Hong Kong, LifeTech, a leading supplier of minimally invasive cardiovascular interventional devices announced its audited overall results for the year ended December 31, 2017.
China Interventional Therapeutics (CIT) 2018 was held at the Suzhou Jinji Lake International Convention Center from March 22 to 25, 2018. LifeTech was invited to the academic event and showed the participants a number of innovative highlights.